CDC Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Buy
7,092,698
+785,644
+12% +$1.13M 5.91% 4
2026
Q1
$8.01M Buy
6,307,054
+2,305,008
+58% +$4.34M 5.09% 7
2025
Q4
$9.56M Buy
+4,002,046
New +$10.9M 4.48% 7

Other funds holding HCAT

CDC Financial's HCAT Position: Q2 2026 in Review

CDC Financial increased its Health Catalyst (HCAT) stake by 12% in Q2 2026, buying an estimated $1.13M and bringing the position to 7,092,698 shares worth $14.1M. The position accounts for 5.91% of the portfolio, ranked #4.

CDC Financial first reported a position in HCAT in Q4 2025 and has held it in 3 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • CDC Financial held 7,092,698 shares of Health Catalyst worth $14.1M as of Q2 2026.
  • CDC Financial bought 785,644 Health Catalyst shares in Q2 2026, an estimated $1.13M.
  • Health Catalyst made up 5.91% of CDC Financial's portfolio in Q2 2026, its #4 holding.
  • CDC Financial first reported a position in Health Catalyst in Q4 2025 and has held it in 3 quarters since.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on CDC Financial's 13F filing for Q2 2026, filed 14 Aug 2026.